Hot Pursuit     23-Feb-24
Concord Biotech gains after receiving GMP certificate with zero observations
Concord Biotech jumped 2.97% to Rs 1,483 after the company received good manufacturing practices (GMP) certificate from Ministry of Health Pharmacy and Poisons Board (PPB), Republic of Kenya for its formulation facility located in Gujarat.
The Ministry of Health Pharmacy and Poisons Board, Republic of Kenya had conducted inspection of Unit II formulation facility located at Valthera-Dholka in Ahmedabad, Gujarat. The said inspection has been completed successfully, without any adverse remarks.

Concord is an India-based R&D-driven biopharma company. The company is ranked among the leading global developers and manufacturers of select fermentation-based active pharmaceutical ingredients (API) across immunosuppressants and oncology in terms of market share, based on volume in 2022.

The company’s consolidated net profit rose marginally to Rs 77.57 crore in Q3 FY24 as compared with Rs 77.37 crore in Q3 FY23. Net sales stood at Rs 240.80 crore in Q3 FY24

Previous News
  Concord Biotech consolidated net profit rises 3.86% in the March 2024 quarter
 ( Results - Announcements 23-May-24   17:16 )
  Concord Biotech to conduct AGM
 ( Corporate News - 31-May-24   16:57 )
  Concord Biotech standalone net profit rises 276.52% in the September 2023 quarter
 ( Results - Announcements 09-Nov-23   07:52 )
  Concord Biotech IPO subscribed 2.72 times
 ( IPO Centre - IPO News 07-Aug-23   17:20 )
  Concord Biotech IPO subscribed 24.86 times
 ( IPO Centre - IPO News 08-Aug-23   17:36 )
  Concord Biotech receives EIR for Unit III at Limbasi
 ( Corporate News - 22-Aug-23   17:40 )
  Concord Biotech consolidated net profit rises 10.62% in the June 2023 quarter
 ( Results - Announcements 07-Sep-23   07:33 )
  Concord Biotech schedules board meeting
 ( Corporate News - 26-Oct-23   17:39 )
  Concord Biotech director resigns
 ( Corporate News - 25-Aug-23   17:58 )
  Concord Biotech IPO subscribed 58%
 ( IPO Centre - IPO News 04-Aug-23   17:15 )
  Concord Biotech consolidated net profit rises 268.78% in the September 2023 quarter
 ( Results - Announcements 09-Nov-23   07:51 )
Other Stories
  Dhanlaxmi Bank gains as gross advances rises 6% YoY in Q1 FY25
  05-Jul-24   15:27
  HDFC Bank Ltd leads losers in 'A' group
  05-Jul-24   15:00
  Shilpa Medicare sizzles after Unicycive gets positive results in clinical trials of OLC
  05-Jul-24   14:52
  Manugraph India Ltd leads losers in 'B' group
  05-Jul-24   14:45
  NSE SME Nephro Care India rallies on listing day
  05-Jul-24   14:45
  ESAF SFB total deposits jumps 33% YoY in Q1
  05-Jul-24   14:43
  Utkarsh SFB deposits climb 30% YoY in Q1 FY25
  05-Jul-24   14:35
  Volumes soar at Medplus Health Services Ltd counter
  05-Jul-24   14:30
  Financials stocks slide
  05-Jul-24   14:00
  Banking stocks edge lower
  05-Jul-24   14:00
Back Top